Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?

Despite a huge effort by the scientific community to determine the animal reservoir of SARS-CoV-2, which led to the identification of several SARS-CoV-2-related viruses both in bats and in pangolins, the origin of SARS-CoV-2 is still not clear. Recently, Temmam et al. reported the discovery of bat c...

Full description

Bibliographic Details
Main Authors: Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2022.2062336
_version_ 1818272405800353792
author Matteo Pavan
Davide Bassani
Mattia Sturlese
Stefano Moro
author_facet Matteo Pavan
Davide Bassani
Mattia Sturlese
Stefano Moro
author_sort Matteo Pavan
collection DOAJ
description Despite a huge effort by the scientific community to determine the animal reservoir of SARS-CoV-2, which led to the identification of several SARS-CoV-2-related viruses both in bats and in pangolins, the origin of SARS-CoV-2 is still not clear. Recently, Temmam et al. reported the discovery of bat coronaviruses with a high degree of genome similarity with SARS-CoV-2, especially concerning the RBDs of the S protein, which mediates the capability of such viruses to enter and therefore infect human cells through a hACE2-dependent pathway. These viruses, especially the one named BANAL-236, showed a higher affinity for the hACE2 compared to the original strain of SARS-CoV-2. In the present work, we analyse the similarities and differences between the 3CL protease (main protease, Mpro) of these newly reported viruses and SARS-CoV-2, discussing their relevance relative to the efficacy of existing therapeutic approaches against COVID-19, particularly concerning the recently approved orally available Paxlovid, and the development of future ones.
first_indexed 2024-12-12T21:41:33Z
format Article
id doaj.art-d44bc14e26c24861905474b8507c7daa
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-12-12T21:41:33Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-d44bc14e26c24861905474b8507c7daa2022-12-22T00:11:02ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742022-12-013711077108210.1080/14756366.2022.2062336Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?Matteo Pavan0Davide Bassani1Mattia Sturlese2Stefano Moro3Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences University of Padova, Padova, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences University of Padova, Padova, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences University of Padova, Padova, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences University of Padova, Padova, ItalyDespite a huge effort by the scientific community to determine the animal reservoir of SARS-CoV-2, which led to the identification of several SARS-CoV-2-related viruses both in bats and in pangolins, the origin of SARS-CoV-2 is still not clear. Recently, Temmam et al. reported the discovery of bat coronaviruses with a high degree of genome similarity with SARS-CoV-2, especially concerning the RBDs of the S protein, which mediates the capability of such viruses to enter and therefore infect human cells through a hACE2-dependent pathway. These viruses, especially the one named BANAL-236, showed a higher affinity for the hACE2 compared to the original strain of SARS-CoV-2. In the present work, we analyse the similarities and differences between the 3CL protease (main protease, Mpro) of these newly reported viruses and SARS-CoV-2, discussing their relevance relative to the efficacy of existing therapeutic approaches against COVID-19, particularly concerning the recently approved orally available Paxlovid, and the development of future ones.https://www.tandfonline.com/doi/10.1080/14756366.2022.2062336SARS-CoV-2bat coronavirussarbecovirusBANALLaosMPro
spellingShingle Matteo Pavan
Davide Bassani
Mattia Sturlese
Stefano Moro
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
Journal of Enzyme Inhibition and Medicinal Chemistry
SARS-CoV-2
bat coronavirus
sarbecovirus
BANAL
Laos
MPro
title Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
title_full Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
title_fullStr Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
title_full_unstemmed Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
title_short Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
title_sort bat coronaviruses related to sars cov 2 what about their 3cl proteases mpro
topic SARS-CoV-2
bat coronavirus
sarbecovirus
BANAL
Laos
MPro
url https://www.tandfonline.com/doi/10.1080/14756366.2022.2062336
work_keys_str_mv AT matteopavan batcoronavirusesrelatedtosarscov2whatabouttheir3clproteasesmpro
AT davidebassani batcoronavirusesrelatedtosarscov2whatabouttheir3clproteasesmpro
AT mattiasturlese batcoronavirusesrelatedtosarscov2whatabouttheir3clproteasesmpro
AT stefanomoro batcoronavirusesrelatedtosarscov2whatabouttheir3clproteasesmpro